Income Statement Polarean Imaging plc
Equities
POLX
GB00BF3DT583
Advanced Medical Equipment & Technology
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.575 GBX | -1.56% | 0.00% | -74.80% |
09-04 | EARNINGS: Gulf Marine backs outlook; Ecora swings to profit | AN |
09-04 | Earnings Flash (POLX.L) POLAREAN IMAGING Posts H1 Revenue $1.1M | MT |
Fiscal Period: December | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|---|---|
Revenues | 2.3M | 1.06M | 1.19M | 1.03M | 891K | |||||
Total Revenues | 2.3M | 1.06M | 1.19M | 1.03M | 891K | |||||
Cost of Goods Sold, Total | 926K | 346K | 677K | 685K | 555K | |||||
Gross Profit | 1.38M | 710K | 508K | 348K | 335K | |||||
Selling General & Admin Expenses, Total | 6.64M | 6.44M | 13.89M | 11.78M | 6.9M | |||||
Stock-Based Compensation (IS) | - | - | - | 1.21M | 860K | |||||
R&D Expenses | - | - | - | - | 4.19M | |||||
Depreciation & Amortization - (IS) | 63.12K | 150K | 177K | 277K | 209K | |||||
Amortization of Goodwill and Intangible Assets - (IS) | 684K | 734K | 757K | 761K | 728K | |||||
Other Operating Expenses, Total | 7.39M | 7.33M | 14.82M | 14.02M | 12.89M | |||||
Operating Income | -6.01M | -6.62M | -14.32M | -13.67M | -12.56M | |||||
Interest Expense, Total | -91.68K | -19.73K | -21.1K | -23.76K | -15.99K | |||||
Interest And Investment Income | 508 | 101K | 2.59K | 35.04K | 299K | |||||
Net Interest Expenses | -91.17K | 81.04K | -18.51K | 11.28K | 283K | |||||
Currency Exchange Gains (Loss) | - | - | 319K | -246K | 388K | |||||
Other Non Operating Income (Expenses) | - | -1 | - | - | - | |||||
EBT, Excl. Unusual Items | -6.1M | -6.53M | -14.02M | -13.91M | -11.88M | |||||
Other Unusual Items | - | - | - | - | - | |||||
EBT, Incl. Unusual Items | -6.1M | -6.53M | -14.02M | -13.91M | -11.88M | |||||
Earnings From Continuing Operations | -6.1M | -6.53M | -14.02M | -13.91M | -11.88M | |||||
Net Income to Company | -6.1M | -6.53M | -14.02M | -13.91M | -11.88M | |||||
Net Income - (IS) | -6.1M | -6.53M | -14.02M | -13.91M | -11.88M | |||||
Net Income to Common Incl Extra Items | -6.1M | -6.53M | -14.02M | -13.91M | -11.88M | |||||
Net Income to Common Excl. Extra Items | -6.1M | -6.53M | -14.02M | -13.91M | -11.88M | |||||
Per Share Items | ||||||||||
Net EPS - Basic | -0.06 | -0.04 | -0.07 | -0.07 | -0.06 | |||||
Basic EPS - Continuing Operations | -0.06 | -0.04 | -0.07 | -0.07 | -0.06 | |||||
Basic Weighted Average Shares Outstanding | 107M | 150M | 197M | 212M | 214M | |||||
Net EPS - Diluted | -0.06 | -0.04 | -0.07 | -0.07 | -0.06 | |||||
Diluted EPS - Continuing Operations | -0.06 | -0.04 | -0.07 | -0.07 | -0.06 | |||||
Diluted Weighted Average Shares Outstanding | 107M | 150M | 197M | 212M | 214M | |||||
Normalized Basic EPS | -0.04 | -0.03 | -0.04 | -0.04 | -0.03 | |||||
Normalized Diluted EPS | -0.04 | -0.03 | -0.04 | -0.04 | -0.03 | |||||
Supplemental Items | ||||||||||
EBITDA | -5.33M | -5.85M | -13.52M | -12.78M | -11.74M | |||||
EBITA | -5.4M | -6M | -13.7M | -13.06M | -11.94M | |||||
EBIT | -6.01M | -6.62M | -14.32M | -13.67M | -12.56M | |||||
EBITDAR | - | - | - | - | - | |||||
Normalized Net Income | -3.81M | -4.08M | -8.76M | -8.69M | -7.43M | |||||
Interest on Long-Term Debt | 16K | 19.73K | 21.1K | 23.76K | 15.99K | |||||
Supplemental Operating Expense Items | ||||||||||
Marketing Expenses | - | - | - | 135K | 257K | |||||
Selling and Marketing Expenses | 325K | 918K | 5.56M | 3.31M | 3.56M | |||||
General and Administrative Expenses | 6.32M | 5.52M | 8.33M | 8.46M | 3.34M | |||||
Research And Development Expense From Footnotes | 155K | 451K | 650K | 619K | 1.75M | |||||
Net Rental Expense, Total | - | - | - | - | - | |||||
Imputed Operating Lease Interest Expense | - | - | - | - | - | |||||
Imputed Operating Lease Depreciation | - | - | - | - | - | |||||
Stock-Based Comp., G&A Exp. (Total) | 306K | 475K | 1.81M | - | - | |||||
Stock-Based Comp., Other (Total) | - | - | - | 1.21M | 860K | |||||
Total Stock-Based Compensation | 306K | 475K | 1.81M | 1.21M | 860K |